دورية أكاديمية
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
العنوان: | A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer |
---|---|
المؤلفون: | Duska, L.R., Krasner, C.N., O'Malley, D.M., Hays, J.L., Modesitt, S.C., Mathews, C.A., Moore, K.N., Thaker, P.H., Miller, A., Purdy, C., Zamboni, W.C., Lucas, A.T., Supko, J.G., Schilder, R.J. |
المصدر: | In Gynecologic Oncology March 2021 160(3):688-695 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!